NCT06532097

Brief Summary

It is well known that physical activity interventions have a robust, if small-to-moderate effect on the amelioration of chronic diseases, including major depressive disorder (MDD) (Singh et al. 2023). At the same time, behavioral activation is one of the most effective components of digital cognitive-behavioral therapy for depression (Furakawa et al. 2021). Here we leveraged smartwatches to provide an interactive tool for delivering a mixed intervention of physical and behavioral activation, with the former addressing physical activity level and the latter pleasant activities including and beyond physical activity (e.g., social, relaxing activities). Moreover, given the relationship with physical activity level, we additionally incorporated digital insomnia exercises that have also shown promising effects in the amelioration of depression. Our primary aim was to estimate the effects of our digital smartwatch-based intervention in a small sample of depressed patients.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
53

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Mar 2023

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2023

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 31, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 31, 2024

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

July 29, 2024

Completed
3 days until next milestone

First Posted

Study publicly available on registry

August 1, 2024

Completed
Last Updated

November 21, 2024

Status Verified

March 1, 2024

Enrollment Period

11 months

First QC Date

July 29, 2024

Last Update Submit

November 19, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • PHQ-9

    Patient Health Questionnaire

    pre to post: 12 weeks

Study Arms (2)

Intervention group

Group of patients that received the digital intervention

Behavioral: Physical and behavioral smartwatch-based activation

Retrospective control group

Retrospectively collected group of patients from earlier versions (amendments) of the study who filled out the PHQ-9 twice with a certain interval (and were offered the intervention at a later time-point)

Interventions

We used smartwatches to provide an interactive tool for delivering a mixed intervention of physical and behavioral activation, with the former addressing physical activity level and the latter pleasant activities including and beyond physical activity (e.g., social, relaxing activities). Moreover, given the relationship with physical activity level, we additionally incorporated digital insomnia exercises that have also shown large effects in the amelioration of depression.

Intervention group

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Unmedicated, depressed patients (mildly or moderately depressed).

You may qualify if:

  • Written consent for voluntary study participation
  • Between 18 and 65 years of age
  • Current diagnosis of a single episode of mild to moderate depressive disorder without psychotic symptoms, according to ICD-10 (F32.0, F32.1)
  • Internet access and email address to answer electronic questionnaires
  • Ability to read German

You may not qualify if:

  • Acute suicidality
  • Pregnancy and breastfeeding
  • Currently undergoing psychological treatment
  • Current use of psychotropic medication
  • Neurological or internal medical disease
  • Diagnosis of a severe major depression or dysthymia according to ICD-10 (F32.2, F32.3, F33.2, F33.3, F34.1)
  • Diagnosis of a psychotic disorder according to ICD-10 (F20-F29) in the life history
  • Diagnosis of a bipolar disorder according to ICD-10 (F31) in life history
  • Acute substance abuse (e.g., drug use or excessive alcohol and nicotine use)
  • Diagnosis of dissociative disorder (F44) in life history

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Max Planck Institute of Psychiatry

Munich, Bavaria, 80805, Germany

Location

MeSH Terms

Conditions

Depression

Interventions

Restraint, Physical

Condition Hierarchy (Ancestors)

Behavioral SymptomsBehavior

Intervention Hierarchy (Ancestors)

Behavior ControlTherapeuticsImmobilizationInvestigative Techniques

Study Officials

  • Victor Spoormaker, PhD

    Max-Planck-Institute of Psychiatry

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 29, 2024

First Posted

August 1, 2024

Study Start

March 1, 2023

Primary Completion

January 31, 2024

Study Completion

January 31, 2024

Last Updated

November 21, 2024

Record last verified: 2024-03

Locations